Medwellai Inc (INTV) Annual Income Statement

Annual · GAAP · USD millions
Access INTV quarterly income statements →
This income statement overview for Medwellai Inc spans from Jun 30 2021 to Jun 30 2025, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2025)
2025
(Jun 30 2024) (Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Revenues
Other Income0.00
Total Interest Income0.05
Net Interest (-)Expense / Income-0.05
Net Interest Income0.00
Total Net Interest Income0.00
Extinguishment of Debt-0.06
Gain (Loss) on Disposition of Assets and Other Investments0.00
Loss / Gain on Investment0.00
Other Non-Interest Income-0.54
Total Non-interest Income0.54
Total Revenues0.59
Costs & Expenses
Salaries & employee benefits, SGA0.07
Restructuring, Accretion & impairment charges0.75
Other Operating Costs0.00
Depreciation & Amortization0.03
Other loss /-income2.69
Total Operating Expenses3.54
Total Costs & Expenses3.60
Income & Taxes
Income /-loss before income taxes-2.95
Income after income taxes-2.95
Net income/-loss of other equity0.00
Income /-loss after income taxes-2.95
Stockholders Equity Attributable to Noncontrolling Interest-0.17
Discontinued Operations-0.83
Net Income/-loss-3.78
Non-controlling interests-0.17
Preferred dividends0.00
Income/-loss to shareholder-3.61
Earnings Per Share
Basic EPS (excl. extra items)-0.49
Extraordinary items-0.15
Basic Net EPS-0.64
Basic shares outstanding (Mill. of Units)6.14
Diluted Net EPS-0.64
Diluted average shares (Mill. of Units)6.14
4 historic quarters locked

Sign in to unlock the full Medwellai Inc income statement history.

About Medwellai Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: September 30, 2025
  • Original filing: intv_10k.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.